title: Life-threatening rituximab-induced pyoderma gangrenosum successfully treated with intravenous immunoglobulin.
authors.affiliation: a Department of Medicine, Clinical Immunology Unit , Stavanger University Hospital , Stavanger , Norway.
authors.forename: J
authors.initials: J
authors.lastname: Vikse
authors.affiliation: b Department of Obstetrics and Gynecology , Stavanger University Hospital , Stavanger , Norway.
authors.forename: A
authors.initials: A
authors.lastname: Rygh
authors.affiliation: c Department of Anaesthesiology and Intensive Care , Stavanger University Hospital , Stavanger , Norway.
authors.forename: K
authors.initials: K
authors.lastname: Kaisen
authors.affiliation: a Department of Medicine, Clinical Immunology Unit , Stavanger University Hospital , Stavanger , Norway.|d Department of Clinical Science, Faculty of Medicine and Dentistry , University of Bergen , Bergen , Norway.
authors.forename: R
authors.initials: R
authors.lastname: Omdal
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000276:immunology; D001323:Autoantibodies / Q000097:blood; D001706:Biopsy / Q000379:methods; D005260:Female; D014890:Granulomatosis with Polyangiitis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects; D008775:Methylprednisolone / Q000008:administration & dosage; D053146:Myeloblastin / Q000276:immunology; D010538:Peritonitis / Q000175:diagnosis / Q000209:etiology / Q000601:surgery; D017511:Pyoderma Gangrenosum / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D012121:Respiration, Artificial / Q000379:methods; D012131:Respiratory Insufficiency / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D000069283:Rituximab / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome; D014623:Vaginal Diseases / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy
chemical_list: D000893:Anti-Inflammatory Agents; D019268:Antibodies, Antineutrophil Cytoplasmic; D001323:Autoantibodies; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D000069283:Rituximab; D053146:Myeloblastin; D008775:Methylprednisolone